» Articles » PMID: 38701438

Diet Modulates the Gut Microbiome, Metabolism, and Mammary Gland Inflammation to Influence Breast Cancer Risk

Overview
Specialty Oncology
Date 2024 May 3
PMID 38701438
Authors
Affiliations
Soon will be listed here.
Abstract

Several studies indicate a strong link between obesity and the risk of breast cancer. Obesity decreases gut microbial biodiversity and modulates Bacteroidetes-to-Firmicutes phyla proportional abundance, suggesting that increased energy-harvesting capacity from indigestible dietary fibers and elevated lipopolysaccharide bioavailability may promote inflammation. To address the limited evidence linking diet-mediated changes in gut microbiota to breast cancer risk, we aimed to determine how diet affects the microbiome and breast cancer risk. For ten weeks, female 3-week-old BALB/c mice were fed six different diets (control, high-sugar, lard, coconut oil, lard + flaxseed oil, and lard + safflower oil). Fecal 16S sequencing was performed for each group. Diet shifted fecal microbiome populations and modulated mammary gland macrophage infiltration. Fecal-conditioned media shifted macrophage polarity and inflammation. In our DMBA-induced breast cancer model, diet differentially modulated tumor and mammary gland metabolism. We demonstrated how dietary patterns change metabolic outcomes and the gut microbiota, possibly contributing to breast tumor risk. Furthermore, we showed the influence of diet on metabolism, inflammation, and macrophage polarity. This study suggests that dietary-microbiome interactions are key mediators of breast cancer risk. Prevention Relevance: Our study demonstrates the impact of diet on breast cancer risk, focusing on the interplay between diet, the gut microbiome, and mammary gland inflammation.

Citing Articles

Gut microbiota interact with breast cancer therapeutics to modulate efficacy.

Arnone A, Ansley K, Heeke A, Howard-McNatt M, Cook K EMBO Mol Med. 2025; 17(2):219-234.

PMID: 39820166 PMC: 11822015. DOI: 10.1038/s44321-024-00185-0.


Endocrine-targeting therapies shift the breast microbiome to reduce estrogen receptor-α breast cancer risk.

Arnone A, Tsai Y, Cline J, Wilson A, Westwood B, Seger M Cell Rep Med. 2025; 6(1):101880.

PMID: 39742868 PMC: 11866439. DOI: 10.1016/j.xcrm.2024.101880.


Bibliometric and visual analysis of human microbiome-breast cancer interactions: current insights and future directions.

Zhou Y, Jiang M, Li X, Shen K, Zong H, Lv Q Front Microbiol. 2024; 15:1490007.

PMID: 39717276 PMC: 11664440. DOI: 10.3389/fmicb.2024.1490007.


A roadmap to reduce the incidence and mortality of breast cancer by rethinking our approach to women's health.

Leggat-Barr K, Yee D, Duralde E, Hodge C, Borges V, Baxter M Breast Cancer Res Treat. 2024; 209(1):1-14.

PMID: 39531132 PMC: 11785669. DOI: 10.1007/s10549-024-07522-4.

References
1.
Urbaniak C, Gloor G, Brackstone M, Scott L, Tangney M, Reid G . The Microbiota of Breast Tissue and Its Association with Breast Cancer. Appl Environ Microbiol. 2016; 82(16):5039-48. PMC: 4968547. DOI: 10.1128/AEM.01235-16. View

2.
. Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants. Lancet. 2016; 387(10026):1377-1396. PMC: 7615134. DOI: 10.1016/S0140-6736(16)30054-X. View

3.
Koliada A, Syzenko G, Moseiko V, Budovska L, Puchkov K, Perederiy V . Association between body mass index and Firmicutes/Bacteroidetes ratio in an adult Ukrainian population. BMC Microbiol. 2017; 17(1):120. PMC: 5440985. DOI: 10.1186/s12866-017-1027-1. View

4.
Soto-Pantoja D, Gaber M, Arnone A, Bronson S, Cruz-Diaz N, Wilson A . Diet Alters Entero-Mammary Signaling to Regulate the Breast Microbiome and Tumorigenesis. Cancer Res. 2021; 81(14):3890-3904. PMC: 8981494. DOI: 10.1158/0008-5472.CAN-20-2983. View

5.
Liu X, Rulina A, Choi M, Pedersen L, Lepland J, Takle S . C/EBPB-dependent adaptation to palmitic acid promotes tumor formation in hormone receptor negative breast cancer. Nat Commun. 2022; 13(1):69. PMC: 8748947. DOI: 10.1038/s41467-021-27734-2. View